MedPath

A GLOBAL, MULTICENTER, PROSPECTIVE, REAL WORLD OBSERVATIONAL STUDY FOR LEFT MAIN DISEASE TREATMENT(IRIS MAIN)

Not Applicable
Conditions
Health Condition 1: I251- Atherosclerotic heart disease of native coronary arteryHealth Condition 2: null- Left Main coronary disease
Registration Number
CTRI/2013/05/003681
Lead Sponsor
SeungJung Park
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

•Significant unprotected left main stenosis ( >50% by visual estimation)

â?¦The LMCA is considered unprotected if there are no patent coronary artery bypass grafts to the left anterior descending artery or the left circumflex artery.

•No limitation of clinical or lesion characteristics

•Age >18 years

•The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

Exclusion Criteria

•Protected left main stenosis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath